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Replicationy stunt virus (TBSV) RNA takes place on the cytosolic membrane surface of
peroxisomes in plants and in yeast, a model host. To identify the host proteins involved in assisting the
peroxisomal localization of the tombusvirus p33 replication protein, we tested if p33 could bind directly to
yeast proteins involved in peroxisomal transport in vitro. This work has led to the demonstration of Pex19p–
p33 interaction via pull-down and co-puriﬁcation experiments. Pex19p was also detected in the tombusvirus
replicase after protein cross-linking, suggesting that Pex19p transiently binds to the replicase as could be
expected from a transporter. To validate the importance of Pex19p–p33 interaction in TBSV replication in
yeast, we re-targeted Pex19p to the mitochondria, which resulted in the re-distribution of a large fraction of
p33 to the mitochondria. The expression of the mitochondrial-targeted Pex19p inhibited TBSV RNA
accumulation by 2–4-fold in vivo and reduced the in vitro activity of the tombusvirus replicase by 80%. These
data support the model that Pex19p is a cellular transporter for localization of p33 replication protein to the
host peroxisomal membranes.
© 2008 Elsevier Inc. All rights reserved.Introduction
Similar to animal viruses, plant viruses containing RNA genomes of
plus-strand polarity replicate on the cytosolic surfaces of intracellular
membranes. For different viruses, these membranes include different
organelles, such as endoplasmic reticulum, mitochondria, chloroplast,
peroxisomes, vacuoles or unique subcellular membranes induced
speciﬁcally by viral infections (Ahlquist et al., 2003; Miller and
Krijnse-Locker, 2008; Nagy and Pogany, 2006; Salonen, Ahola, and
Kaariainen, 2005; Snijder et al., 2006). Why different viruses choose
different subcellular membranes for their replication and how the
viral replication proteins are targeted to those membranes are
currently under intensive investigations. Once the replication proteins
and the viral RNA are delivered to the precise membrane locations,
then they form, likely with the help of yet unidentiﬁed host proteins,
membrane invaginations (called spherules) that contain narrow
openings facing toward the cytosol (Schwartz et al., 2002). These
spherules contain the viral replicase complex and are the places for
viral RNA synthesis (Kopek et al., 2007; McCartney et al., 2005;
Schwartz et al., 2002).
Targeting of the viral replication proteins to the particular
membrane location is likely driven by host transport proteins that
might recognize speciﬁc targeting signals within the viral replication
proteins. In spite of intensive studies, we know only a few cases, wherel rights reserved.host proteins are implicated in intracellular transport of the viral
replication proteins. For example, the 126 K replication protein of
Tobacco mosaic virus (TMV) is bound to TOM1 and TOM2 transmem-
brane proteins, whichmight anchor the TMV replication protein to the
membrane (Hagiwara et al., 2003). Also, the transport of BMV
replication proteins and the BMV (+)RNAs within the host cells is
affected by the Lsm1-7p/Pat1p/Dhh1p complex (Beckham et al.,
2007). This complex has been suggested to facilitate the pre-assembly
of the BMV replicase complex in the P-bodies, prior to the
transportation of the viral replication proteins and RNAs to the ER,
the site of replication (Beckham et al., 2007).
Interaction of the NS5A and NS5B replication proteins of hepatitis C
virus (HCV) with intracellular membranes is affected by hVAP-A
SNARE-like protein. The proposed function of hVAP-A is to serve as a
membrane receptor and to anchor the replication proteins to the
intracellular membrane (Tu et al., 1999). Moreover, FBL2, a geranyl-
geranylated cellular protein might be involved in recruitment of HCV
NS5A to intracellular membranes (Wang et al., 2005). Overall, none of
the above cellular proteins ﬁt to the deﬁnition of a traditional
transporter protein, which is expected to be released and recycled
from themembrane after delivering the cargo viral proteins/viral RNA.
Among the (+)RNA viruses of plants, tombusviruses have emerged
as highly suitable model viruses for studying basic questions in viral
RNA replication and recombination, including the role of the host
(Nagy and Pogany, 2006, 2008). The genomic (+)RNA of TBSV and the
closely related Cucumber necrosis virus (CNV) codes for p33 and p92pol
replication proteins, which are produced via translational readthrough
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factor involved in selection/recruitment of the viral RNA template
(Monkewichet al., 2005; Panavas et al., 2005a; Poganyet al., 2005), and
in the assembly of the viral replicase (Panaviene et al., 2005), whereas
p92pol is a RNA-dependent RNA polymerase (RdRp) (Oster, Wu, and
White, 1998; Panavas and Nagy, 2003; Panaviene et al., 2003). Both
replication proteins are integral parts of the tombusvirus replicase
complex in combinationwith 4–10 host proteins (Rajendran and Nagy,
2006; Serva and Nagy, 2006; Wang and Nagy, 2008). One of the major
breakthroughs in tombusvirus research is the development of yeast as
a model host for virus–host interactions, allowing the utilization of
powerful genomics and proteomics tools developed for yeast (Panavas
and Nagy, 2003). Yeast cells expressing tombusvirus p33 and p92pol
replication proteins can efﬁciently replicate a short TBSV-derived
replicon (rep)RNA, which is a defective interfering (DI) RNA identiﬁed
in TBSV infected plants (Panavas and Nagy, 2003; Panaviene et al.,
2004). The tombusviral repRNA not only serves as a template for
replication, but as an assembly platform for the viral replicase complex
as well (Panaviene et al., 2005, 2004).
Replication of both TBSV and CNV RNAs takes place on the
cytosolic surfaces of the peroxisomal membranes in plant and yeast
host cells (McCartney et al., 2005; Panavas et al., 2005a). The
peroxisomal membranes contain the typical virus-inducedmembrane
spherules and the viral replicase (McCartney et al., 2005; Panavas et
al., 2005a), suggesting that transport of the viral replication proteins
to peroxisomal membranes likely occurs in TBSV infected cells.
Deletion analysis of the p33 replication cofactor in combination with
intracellular localization studies revealed that three redundant
peroxisomal targeting sequences are present in p33 (McCartney et
al., 2005). Unfortunately, among ∼160 host genes identiﬁed in recent
systematic genome-wide screens of single gene knock out library and
the essential gene library of yeast that affected TBSV replication or
recombination (Jiang et al., 2006; Panavas et al., 2005b; Serviene et al.,
2006, 2005), we could not yet identify any outstanding host protein
candidates for transportation of the tombusvirus replication proteins
to the peroxisomes. This is likely due to gene/functional redundancy
within the yeast host. Indeed, later works demonstrated that
replication of TBSV and the closely related Cymbidium ringspot virus
(CyRSV) was able to switch to the ER membrane in the absence of
peroxisomes in yeast (Jonczyk et al., 2007; Rubino et al., 2007). This
unexpected ﬁnding suggested that the membrane requirement for
tombusvirus replication is ﬂexible and that tombusvirus replication
proteins can be transported to the ER by default (Jonczyk et al., 2007).
The objective of this work was to identify the host transporter
protein for p33 replication cofactor to the peroxisomal membrane,
where TBSV RNA replication takes place (McCartney et al., 2005;
Panavas et al., 2005a). We reasoned that p33 likely interacts with host
proteins involved in intracellular trafﬁcking of peroxisomal mem-
brane proteins. To identify those host proteins that could be involved
in transportation of the tombusvirus p33 replication co-factor to
peroxisomal membranes, we tested whether yeast proteins involved
in transport to peroxisome membrane could bind to p33 in vitro.
These preliminary experiments have led to the identiﬁcation of
Pex19p that bound to p33 speciﬁcally under in vitro conditions.
Further approaches validated that the Pex19p–p33 interaction is
important for intracellular transport of p33. Altogether, data pre-
sented in this work support the model that Pex19p is the transporter
for p33 replication protein.
Results
The Pex19p host protein binds to the tombusvirus p33 replication
cofactor in vitro
To identify if one of the yeast proteins involved in transportation of
membrane proteins to the peroxisome could interact with p33replication cofactor, we performed preliminary pull-down experi-
ments with puriﬁed recombinant p33 fused with the Maltose binding
protein (MBP) immobilized on beads and 5 separately expressed GST-
tagged host proteins affecting transport to peroxisomes. These
experiments have shown that Pex19p bound to MBP-p33, but only
poorly to the MBP control (Fig. 1B, lane 1 versus 2). The GST protein
expressed in yeast serving as a control for Pex19p-GST, did not bind to
MBP-p33 in the pull-down experiments, conﬁrming that the in vitro
interaction took place between Pex19p and p33 and was not
facilitated by the sequence tags.
To test if the previously deﬁned three peroxisomal membrane-
targeting sequences (mPTS) in p33 (McCartney et al., 2005) are
important for the interaction with Pex19p, we puriﬁed recombinant
MBP-p33 proteins with deﬁned deletions. These experiments revealed
that p33ΔPTS that lacked all three mPTS sequences (Fig. 1A) bound
poorly to Pex19p in the pull-down experiment (Fig. 1C, lane 3).
Similarly, p33C, whichmisses the entire N-terminal domain, including
the 3mPTS sequences and the two predicted transmembrane domains
(Fig. 1A) bound poorly to Pex19p in vitro (Fig. 1C, lane 4). Deletion of
the N-terminal 11 amino acids in p33, which includes one of the mPTS
sequences and an ER-targeting sequence (McCartney et al., 2005), did
not inhibit its binding to Pex19p in vitro (Fig. 1C, lane 2). Interestingly,
deletion of short N-terminal stretches did not inhibit the peroxisomal
localization of p33 in N. benthamiana or yeast cells (Panavas et al.,
2005a), whereas deletion of all three mPTSs did inhibit p33
localization (McCartney et al., 2005).
To deﬁne if the C-terminal sequence of Pex19p is involved in
interaction with p33, we tested a C-terminally-truncated Pex19p,
termed Pex19-N206. The C-terminal portion of Pex19p is known to
bind to other cargo peroxins that are transported to the peroxisomal
membrane by Pex19p (Matsuzono et al., 2006). The in vitro pull-down
experiment has shown that Pex19-N206 did not bind to p33 (Fig. 1D,
lane 2). This was expected, since the N-terminal portion of Pex19p is
involved in binding to Pex3p docking protein, not to the cargo proteins
(Matsuzono et al., 2006).
Co-puriﬁcation of p33 replication protein with Pex19p host protein
from yeast
To test if Pex19p and p33 replication cofactor form a complex in
yeast, ﬁrst we cross-linked proteins with formaldehyde in intact yeast
cells co-expressing GST-Pex19p and p33HF (6xHis/FLAG-tagged),
followed by quenching with glycine. Then, the cells were broken
and GST-Pex19p was afﬁnity puriﬁed. Western blot analysis of the
GST-afﬁnity puriﬁed Pex19p revealed that p33HF was readily co-
puriﬁed with GST-Pex19p, but not with GST (Fig. 2A, lane 1 versus 3).
To test if the presence of the peroxisomal membrane is important
for p33 and Pex19p interaction, we repeated the co-puriﬁcation
experiment from pex3Δ yeast, which lacks peroxisomes and perox-
isomal “ghosts” or membranes (Hoepfner et al., 2005; Kragt et al.,
2005; Lazarow, 2003; Tam et al., 2005). We co-puriﬁed p33 from
pex3Δ yeast, suggesting that the peroxisomal membrane is not
necessary for Pex19p–p33 interaction. Since the co-puriﬁed p33 was
less from pex3Δ yeast than from the wt yeast, it is possible that the
peroxisomal membrane might increase/stabilize the Pex19p–p33
interaction. We also tested if the 3 mPTS sequences are important
for p33 co-puriﬁcation with Pex19p. These experiments have demon-
strated that p33ΔPTS that lacked all three mPTS sequences (Fig. 1A)
was not co-puriﬁed efﬁciently with GST-Pex19p (Fig. 2B, lane 3),
whereas p33ΔN11 with deletion of the N-terminal 11 amino acids
[that includes one of the mPTS sequences and an ER-targeting
sequence (McCartney et al., 2005)], was co-puriﬁed with Pex19p
(Fig. 2B, lane 4). Overall, these co-puriﬁcation data from intact yeast
cells are in agreement with the in vitro binding experiments, further
supporting the model that the mPTS sequences in p33 are important
for p33–Pex19p interaction.
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To test if Pex19p is present within the membrane-associated
tombusvirus replicase, we puriﬁed the replicase from yeast activelyreplicating the TBSV repRNA. We have used a two-step puriﬁcation
procedure based on FLAG-6xHis double-tagged p33 solubilized from
the membrane fraction of yeast lysate that results in a replicase
preparation, which still has RNA-dependent RNA polymerase activity
Fig. 2. Co-puriﬁcation of p33 with Pex19p from yeast. (A) GST-Pex19p or GST were puriﬁed via GST-afﬁnity puriﬁcation from the wt (BY4741) and pex3Δ yeast co-expressing the
FLAG/6xHis-tagged p33HF. Proteins were cross-linked with formaldehyde in intact yeast cells, followed by quenching with glycine, breaking the cells and afﬁnity puriﬁcation. The
Western-blotting was done with anti-FLAG antibody to detect the co-puriﬁed p33HF (lanes 1–4). Total proteins were analyzed with Western blotting using anti-GST antibody
(lanes 5–8). (B) Demonstration of co-puriﬁcation of p33 derivatives with GST-Pex19p. The Western-blotting was done with anti-FLAG antibody. See further details in panel A.
Asterisk marks the co-puriﬁed minute amount of p33ΔPTS.
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p33 and p92pol (Serva and Nagy, 2006). Western blot analysis of the
two-step puriﬁed tombusvirus replicase using anti-Pex19p antibody
revealed trace amount of Pex19p, which was absent in the control
preparation (Fig. 3, lane 3 versus 4). The control was prepared using
the same procedure, but the sample was based on yeast expressing a
single 6xHis-tagged p33 (Serva and Nagy, 2006).
As Pex19p is known to interact with other peroxins only
temporarily (Hettema et al., 2000; Rottensteiner et al., 2004), we
cross-linked proteins with formaldehyde prior to breaking the cells,
followed by the above two-step afﬁnity puriﬁcation. Western blotting
with anti-Pex19p antibody revealed that Pex19p was present in the
highly puriﬁed replicase preparation, while it was missing in the
control preparations (Fig. 3, lanes 1 versus 2). Altogether, the higher
recovery rate for Pex19p in the cross-linked samples than in the
uncross-linked preparations (Fig. 3, lanes 1 versus 3) supports that
Pex19p is likely present in the tombusvirus replicase temporarily.
Re-targeting Pex19p to the mitochondria leads to redistribution of p33
Finding evidence that supports the relevance of Pex19p in
tombusvirus replication is challenging for several reasons. First,
deletion of PEX19 results in the complete loss of peroxisomes in yeastFig. 1. In vitro interaction between Pex19p and p33 depends on the redundant peroxisomal ta
deletionderivativesused in this study.mPTS indicates threeperoxisomal targeting sequences, all
phosphorylation site;RPR is a proline-arginine-richmotif involved inviral RNAbinding;while S1
are represented with thin lines. (B) A pull-down experiment demonstrates interaction betwee
immobilized on afﬁnity beads. GST-Pex19p (top panel) or the control GST (bottompanel), both o
afﬁnity columnswith immobilizedMBP-p33 or the controlMBP. This panel shows theWestern a
3–4). (C)Western blot analysis of GST-Pex19p bound to the afﬁnity columnswith immobilizedM
of interaction between p33 and a Pex19p mutant in vitro. Pex19p-N206 lacks the C-terminal 13(Lazarow, 2003). Second, p33 is re-targeted to the ER in pex19Δ yeast
that could be due to the lack of Pex19p or the absense of peroxisomal
membranes. Moreover, TBSV replication takes place efﬁciently in the
ER membrane in pex19Δ yeast (Jonczyk et al., 2007), due to apparent
functional redundancy in the cell that can support TBSV replication.
To circumvent the above problems, we redirected Pex19p to the
mitochondria using a strong viral mitochondrial targeting sequence
[MTS, derived from the N-terminal portion of Carnation Italian ringspot
virus, CIRV (Weber-Lotﬁ et al., 2002)]. We reasoned that if Pex19p
interacts with p33 in the cell, then MTS-Pex19p should re-direct the
localization of a fraction of p33 to the mitochondria. Confocal laser
microscopy analysis revealed that p33-YFP co-localized with a mito-
chondrial marker (MTS-CFP) (Weber-Lotﬁ et al., 2002) in yeast co-
expressing MTS-Pex19p (Fig. 4., panel A). The co-localization occurred
even at an early time point (7 h), suggesting that MTS-Pex19p can
redirect p33-YFP to themitochondria. Similar mitochondrial localization
of p33-YFP was observed in pex19Δ yeast expressing MTS-Pex19p (Fig.
4A, right panels). Over-expression of the 6xHis-tagged Pex19p did not
lead to co-localization of p33-YFP and MTS-CFP (Fig. 4B). Moreover,
expression of MTS-CFP in the absence of MTS-Pex19p in wt BY4741 or
pex19Δ yeast did not lead to co-localization of p33-YFP and MTS-CFP
(Fig. 4C), arguing against the possible role of MTS-CFP in the
mitochondrial localization of p33-YFP in yeast also over-expressingrgeting sequences in p33. (A) Schematic representation of known domains in p33 and its
ofwhichare deleted inp33ΔPTS; TMD is thepredicted transmembranedomain;P indicates
and S2 represent subdomains involved inp33:p33/p92 interactions. Thedeleted sequences
n p33 and Pex19p in vitro. The puriﬁed recombinant MBP-p33 or the control MBP were
f which carry a 6xHis tag, were expressed inyeast and the yeast lysateswere applied to the
nalysis (lanes 1–2 and 5–9)with anti-His antibody or the coomassie blue stained gel (lanes
BP-p33 derivatives orMBP as a control. (D) A pull-down experiment demonstrates the lack
7 amino acids involved in binding to cargo peroxin proteins. See further details in panel B.
Fig. 3. Temporary presence of Pex19p in the viral replicase preparation. Protein cross-
linking was done in intact yeast cells as described in Fig. 2. The yeast cells expressed
p33/p92 and TBSV repRNA from plasmids and wt Pex19p from its natural chromosomal
location. The membrane-enriched fraction of yeast was solubilized with 1% NP-40+5%
SB3-10 detergents, followed by a two-step afﬁnity puriﬁcation of p33HF based on nickel
and FLAG columns. The presence of Pex19p was detected with Western blotting of the
proteins eluted from the afﬁnity columns using anti-Pex19p antibody. Note that the
control p33H (single 6xHis-tagged) samples were also used for two-step puriﬁcation to
identify nonspeciﬁc binders to the columns. The position of the wt monomeric Pex19p
is marked with an arrow. The trace amount of Pex19p present in the puriﬁed sample
obtained without cross-linking is indicated with an asterisk. A slower migrating
Pex19p-speciﬁc band in the puriﬁed samples could be either Pex19p dimer or Pex19p–
p33 heterodimer (not fully denatured by heating the samples at 100 °C). The presence of
this band does not change the interpretation of the data, because it is only present in the
samples also containing p33HF andmonomeric Pex19p (lanes 1 and 3), excluding that it
is a contaminating protein nonspeciﬁcally recognized by the anti-Pex19p antibody.
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with themodel that re-targeting of Pex19p to themitochondria results in
re-localization of p33-YFP to the mitochondria as well.
Re-targeting Pex19p to the mitochondria interferes with TBSV repRNA
accumulation
Re-targeting of the tombusvirus replication proteins to the mito-
chondria via expression of MTS-Pex19p might cause problems during
the assembly of the viral replicase, because other key peroxisomal
membraneproteins, such as Pex3p dockingprotein,which is localized to
the peroxisomes via the ER pathway and not via the cytosolic Pex19p-
driven pathway (Hoepfner et al., 2005; Kragt et al., 2005), will not be
present in themitochondrialmembrane. To test the effectof re-targeting
of MTS-Pex19p-p33 complex to the mitochondrial membranes, we
measured TBSV repRNA accumulation in yeast cells expressing 6xHis-
tagged MTS-Pex19p. These experiments have shown 60% reduction in
TBSV repRNA accumulation when compared with yeast expressing a
short peptide from the pYES plasmid (compare lanes 4–6 with 10–12 in
Fig. 5A). Additional control was yeast expressing 6xHis-tagged Pex19p,
which affected TBSV repRNA accumulation by less than 30% inwt yeast,
whereas expressing HisMTS did not affect repRNA accumulation (Fig.
5A, lanes 1–3 and 7–9). The trend was similar in pex19Δ yeast, in which
the re-targeted 6xHis-tagged MTS-Pex19p inhibited TBSV repRNA
accumulation (lanes 24–26), while the control proteins did not. Overall,
these data are consistentwith amodel that the re-targetedMTS-Pex19p
can interfere with TBSV replication.
Since the expression level of 6xHis-tagged MTS-Pex19p was low in
yeast (Fig. 5B, lanes 4–6 and 24–26), we also expressed MTS-Pex19p,
which was expressed to a level comparable to that of His-Pex19p (Fig.
5C). In these experiments, we used p33-YFP, and p92H replication
proteins to support TBSV repRNA replication, because the evidence on
re-distribution of p33 to the mitochondria was obtained using this
system (see Fig. 4). We found that expression of MTS-Pex19p inhibited
TBSV repRNA accumulation by 70–75% in wt and pex19Δ yeast (Fig.
5C), conﬁrming the dominant negative effect of MTS-Pex19p on TBSV
replication.Re-targeting Pex19p to the mitochondria decreases the efﬁciency of the
tombusvirus replicase
Re-targeting of the tombusvirus replication proteins to the
mitochondria via expression of the dominant negative MTS-Pex19p
could inhibit TBSV replication due to several reasons, including
affecting the assembly of the viral replicase. To test if the viral
replicase is active in yeast expressing MTS-Pex19p, we isolated the
tombusvirus replicase, which was present in a membrane-enriched
fraction. This replicase preparation is highly active in vitro (Panaviene
et al., 2005, 2004), as shown in the control sample obtained fromyeast
expressing a short peptide from pYES plasmid (Fig. 6A, lanes 10–12).
On the contrary, the replicase preparation obtained from yeast
expressing MTS-Pex19p showed poor replicase activity (down by
80%, Fig. 6A, lanes 1–3), albeit the amount of p33 replication protein
was comparable to the control samples (Fig. 6B, lane 3 versus lanes 1
and 2). The additional control replicase samples obtained from yeast
expressing either 6His-tagged Pex19p or MTS-CFP showed 100% and
70% activities, respectively (Fig. 6A, lanes 4–9). Overall, the in vitro
assays revealed that the activity of the tombusvirus replicase is poor
when isolated from yeast expressing the functional viral replication
proteins in the presence of the re-targeted MTS-Pex19p.
Discussion
The assembly of replicase complexes of (+)RNA viruses requires the
targeting of the viral replication proteins from the site of translation
(cytosol or rough ER) to specialized subcellular membranes (Mackenzie,
2005; Salonen et al., 2005). For example, the tombusvirus p33 and p92pol
replication proteins are targeted to the peroxisomal membranes in plant
and wt yeast cells (McCartney et al., 2005; Panavas et al., 2005a). For the
targeting of the viral replication proteins, tombusviruses might take
advantage of host proteins involved in subcellular protein transportation.
Indeed, this work shows evidence that Pex19p could serve as a
transporter for the p33 replication protein in the yeast model host. The
following evidence has been obtained: (i) the binding of Pex19p to p33
requires the 3 mPTS sequences in p33, which are also known to be
essential for peroxisomal targeting inplant cells (McCartney et al., 2005);
(ii) Pex19p was shown to be present, at least temporarily, in the viral
replicase complex (Fig. 3); (iii) re-targeting the Pex19p to the mitochon-
dria has led to re-distribution of p33 to the mitochondria as well; (iv)
Pex19p with the mitochondrial targeting sequence had a dominant
negative effect on TBSV repRNA accumulation; and (v) expression of the
MTS-Pex19p also reduced the activity of the tombusvirus replicase.
Based on the above evidence, we propose that Pex19p is the
primary transporter of tombusvirus p33 replicationprotein (Fig. 7, step
1), and likely p92pol as well due to the presence of overlapping
sequence at the N-terminus of p92pol and the requirement of the
N-terminal region of p92pol for peroxisomal localization (Panavas et al.,
2005a). It is also possible that a fraction of p92pol is ‘piggy-backing” on
p33 to reach to the peroxisomal membranes (Panavas et al., 2005a).
Based on the proposed function of Pex19p in yeast, it is likely that the
Pex19p–p33 complex can directly reach the peroxisome from the
cytosol (Fig. 7A, step 2), without entering the ER or the Golgi
compartment (Hettema et al., 2000; Lazarow, 2003). After reaching
the peroxisomal membrane, the Pex19p–p33 complex might bind to
Pex3p, which is the docking protein for Pex19p (Fang et al., 2004).
Binding to Pex3p might facilitate the unloading of the cargo p33 from
Pex19p, which could then be recycled to the cytosol for new rounds of
transport (Fig. 7A, step 3).
What makes the function of Pex19p in tombusvirus replication
difﬁcult to study is the presence of a default pathway that targets
p33/p92pol efﬁciently to the ER in the absence of the peroxisomes
(Jonczyk et al., 2007; Panavas et al., 2005a; Rubino et al., 2007). Thus,
the function of Pex19p is not essential for tombusvirus replication in
yeast. Yet, re-targeting of Pex19p to the mitochondria inhibited TBSV
Fig. 4. Re-targeting Pex19p via an MTS sequence leads to mitochondrial localization of a fraction of p33 replication protein. (A) Confocal laser microscopy analysis of subcellular
localization of p33 in the presence of mitochondrial-targeted Pex19p. The images were taken at 24 or 7 h time points. MTS-Pex19p and p33-YFP were expressed from the GAL1
promoter, whereas the mitochondrial marker MTS-CFP was expressed from ADH1 promoter in wt BY4741 (left panels) or pex19Δ (right panels) yeast cells. (B) Confocal laser
microscopy analysis of subcellular localization of p33 in the presence of cytosolic Pex19p (6xHis-tagged). A false color, blue/red image is shown on the right to highlight the lack of co-
localization in themerged image. See further details in panel A. (C) Confocal laser microscopy analysis of subcellular localization of p33 in the presence of mitochondrial-targeted CFP.
Note that the expression of MTS-CFP did not result in re-localization of p33-YFP to the mitochondria.
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dominant negative function of MTS-Pex19p suggests that the
peroxisomal pathway for tombusviruses is the primary pathway,
while the ER targeting pathway is secondary. Moreover, we interpret
the dominant negative effect of MTS-Pex19p as the consequence of
the inappropriate environment in the mitochondrial membrane for
assembling fully functional viral replicase complexes. It is possible
that the short N-terminal sequence of p33 adapted to the
peroxisomal membrane is not fully-functional when inserted into
the outer membrane of the mitochondria. In addition, the MTS-
Pex19p–p33 complex could be more stable in the mitochondrial
membrane due to the absence of Pex3p docking protein than in the
peroxisomal membrane where Pex3p is present to recycle Pex19p.Also, due to the transmembrane domains within the MTS sequence,
MTS-Pex19p likely stays integrated into the mitochondrial mem-
brane, where it could inhibit p33 functions. Unfortunately, we
cannot study the effect of Pex19p–p33 complex on the viral replicase
in the peroximal membrane in the absence of Pex3p, because there
are no peroxisomes present in pex3Δ yeast (Hettema et al., 2000;
Hoepfner et al., 2005).
We should mention that the mitochondrial environment could be
supportive for tombusviruses, since CIRV does replicate on the surfaces
of the mitochondria (Weber-Lotﬁ et al., 2002). In addition, re-targeting
CyRSV p33/p92 proteins from peroxisomes to the mitochondria via
replacing the mPTS-carrying N-terminal sequence with the longer MTS
sequence in p33/p92pol resulted in active CyRSV replication (Burgyan
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that, in these experiments, the mitochondrial transport system was
likely recruited by the chimeric tombusvirus replication proteins
carrying MTS, thus resulting in proper transport and unloading of thereplication proteins to the outer membrane of the mitochondria.
Alternatively, the original N-terminal sequence of p33 does not have the
optimal sequence for the proper insertion to the mitochondrial
membrane, unlike the chimeric MTS-p33/p92pol proteins that carried
Fig. 6. Reduced replicase activity of preparations obtained from yeast expressing the
mitochondrial targeted MTS-Pex19p. (A) Standard tombusvirus replicase assays with
membrane-enriched fraction prepared from BY4741 yeast cells expressingMTS-Pex19p,
6xHis-tagged Pex19p, MTS-CFP or a short peptide from pYES are shown. Note that these
replicase preparations contain the co-puriﬁed repRNA, which is used as a template
during the in vitro assay in the presence of 32P-UTP and cold additional ribonucleotides.
The replicase activity of the preparation obtained fromyeast carrying pYES was taken as
100%. (B) Western blot analysis of p33-YFP (6xHis-tagged) and the co-expressed
proteins using anti-His antibody. The yeast samples were the same as used in the
replicase assay in panel A.
301K.B. Pathak et al. / Virology 379 (2008) 294–305the entire N-terminal portion of CIRV p36 protein, which are adapted to
themitochondrial membrane, where CIRV replicates (Weber-Lotﬁ et al.,
2002). Altogether, in our experiments, the p33 tombusvirus replication
protein did not have MTS, and therefore its transport, unloading and/or
insertion to the outer membrane of the mitochondria as the MTS-
Pex19p /p33 complex could have taken place qimproperlyq, thus,
inhibiting the assembly/function of the viral replicase complex.
The known cellular functions of Pex19p ﬁt well with the proposed
role in p33 transportation to the peroxisomes. Pex19p is a cytosolic
chaperone protein that binds to selected peroxin proteins and targets
them for insertions to the peroxisomal membranes with the help of the
Pex3p docking protein (Fang et al., 2004; Hettema et al., 2000;
Rottensteiner et al., 2004). Re-cycling of the Pex19p after cargo delivery
to the cytosol allows the multiple use of this protein for transport.
Altogether, this work adds Pex19p as a new host factor to the growing
list of host factors that are involved in tombusvirus replication. Future
experiments will address if Pex19p is also involved in recruitment of
additional host proteins to the viral replicase complex.
Materials and methods
Yeast strains
Saccharomyces cerevisiae strains BY4741α (MATa his3Δ1 leu2Δ0
met15Δ0 ura3Δ0) and its derivatives Pex19Δ and Pex3Δwere obtainedFig. 5. Dominant negative effect of the mitochondrial targeted MTS-Pex19p on TBSV replicat
pex19Δ (right panels) yeast cells co-expressing the 6xHis-tagged MTS-Pex19p with p33/p92
sequence and a short peptide from pYES. RepRNA accumulation in yeast carrying pYES was t
done with Imagequant software. The experiments were repeated 3–8 times. (B) Western blo
Asterisks point at the host proteins expressed with various tags as shown. The yeast samples
BY4741 (left panels) or pex19Δ (right panels) yeast cells co-expressing MTS-Pex19p (without
See further details in panel A. The Western blot (bottom panel) was done using anti-Pex19pfrom Open Biosystems (Huntsville, AL, USA). The yeast GST-ORF over-
expression library was provided by Dr Brenda Andrews, University of
Toronto, Ontario, Canada.
Yeast and Escherichia coli plasmids
pEG(KT/KG)-GST6xHis-pex19 and pEG(KT/KG)-GST6xHis were from
the yeast GST library (Sopko et al., 2006). pESC-DI72-p33, co-expressing
6xHis-tagged p33 of CNV from the GAL1 promoter and TBSV DI-72
repRNA from theGAL10 promoter was obtained as follows: The p33 ORF
with the N-terminal 6xHis-tag was ampliﬁed by high-ﬁdelity PCR using
primer #1402 (GCGGCAGATCTTACCAT-GGGGGGTTCTCA) and #1403
(GCCGCTCGAGCTATTTCACACCAAGGGACTCA) and then ligated to pESC
vector (Invitrogen) digested with BamHI and XhoI. In addition, the full-
length cDNA of DI-72(+), including the 3′ ribozyme (Panaviene et al.,
2004) was cloned between EcoRI and SacI sites. Construct pESC-DI72-
YFPp33 expressing 6xHis-tagged p33 and the yellow ﬂuorescent protein
(YFP) at the N-terminus from the GAL1 promoter was described earlier
(Jonczyk et al., 2007; Panavas et al., 2005a). Plasmids pGBK-HF33 and
pGAD-HF92 expressing 6xHis/FLAG-tagged p33 and 6xHis/FLAG-tagged
p92, respectively, were described previously (Serva and Nagy, 2006).
pHisGBK-His33 and pGAD-His92, expressing 6xHis-tagged p33 and
6xHis-tagged p92, respectively from the constitutive ADH1 promoter
were described (Panavas and Nagy, 2003).
For the in vitro binding assays, we used pMAL-33 (full length),
pMAL-33C, andpMAL-emptyas described earlier (Rajendran andNagy,
2003). To obtain pMAL-p33ΔN11, a portion of p33 ORF was ampliﬁed
by PCR using primers #2020 (GAGGAATTCGAAATTTTTATTGG-
CACGTTC) and#871 (CCCGTCTAGAGGCCTCCCTATTTCACACCAAGGGA),
followed by cleavage with EcoRI and XbaI and directional cloning into
vector pMAL-c2X digested with same pair of restriction enzymes.
pMAL-p33ΔPTS was constructed by a two-step ligation of p33 cDNA
fragments. The 5′ portion of the p33 ORFwas ampliﬁedwith PCR using
primers #2020 and #1703 (GCCGCTAGCCCATTTGGCTGCACAATCTGT),
followed by treatment with EcoRI and NheI. A 3′ portion downstream
from the 130 aa position of p33 was ampliﬁed using primers #2041
(GCCGCTAGCCCTAAGAAAGGCTTGCTACTG) and #871, followed by
cleavage with NheI and XbaI. After gel-isolation of both PCR products,
we ligated them and then used PCR with primers #2041 and #871 to
amplify the correctly ligated PCR product. The obtained PCR product
was cloned into pMAL-c2X digested with EcoRI and XbaI.
To obtain pESC-DI72-HisFLAGp33, the p33 ORF together with the
N-terminal 6xHis/FLAG tag was ampliﬁed from pGBK-HF33 (Serva and
Nagy, 2006) by using primers #1402 (GCGGCAGATCTTAC-
CATGGGGGGTTCTCA) and #1403 (GCCGCTCGAGCTATTTCACAC-
CAAGGGACTCA) digested with BglII and XhoI and then ligated to
pESC digested with BamHI and XhoI. For generating the pESC-
HisFLAGp33ΔN11 and pESC-HisFLAGp33ΔPTS, the ORFs of p33ΔN11
and p33ΔPTS were ampliﬁed by PCR from pMAL-p33ΔN11 and pMAL-
p33ΔPTS using primers #2222 (CGACGGATCCAAAGAAATTTTTATTGG-
CACGTTCGCGA) and #1403 (GCCGCTCGAGCTATTTCACACCAAGG-
GACTCA), followed by digestion of the PCR product with BamHI and
XhoI and cloning into pESC-HisFLAGp33 plasmid digested with the
same pair of restriction enzymes.
To obtain pYES-HIS-PEX19, the PEX19 ORF was ampliﬁed by PCR
from yeast genomic DNA with primers #1915 (CCCGGATCCATGC-
CAAACATACAACACGAAGTAATG) and #1916 (CCCCTCGAGT-
TATTGTTGTTT-GCAACCGTCGGT), followed by cloning into pYES at
BamHI and XhoI sites.ion. (A) Northern blot analysis of TBSV repRNA accumulation in BY4741 (left panels) or
/repRNA. The control yeast samples contained 6xHis-tagged Pex19p, 6xHis-tagged MTS
aken as 100%. The 18 S ribosomal RNAwas used as a loading control. Quantiﬁcation was
t analysis of p33 (6xHis-tagged) and the co-expressed proteins using anti-His antibody.
were the same as used for Northern blotting in panel A. (C) Accumulation of repRNA in
extra-tag) and p33/p92/repRNA. We analyzed 12 independent samples per experiment.
antibody.
Fig. 7.Amodel for the proposed transporter function of Pex19p during tombusvirus replication. (A) In thewt yeast cells, the cytosolic Pex19p is proposed to bind to p33 replication co-
factor after translation and shuttle p33, which likely forms a multiprotein-viral RNA complex as shown, to the peroxisomal membrane. There, the membrane-bound Pex3p “cargo-
docking” protein might help unloading the p33 cargo and recycling the Pex19p protein to the cytosol. (B) In the absence of Pex19p in pex19Δ yeast, an unknown host protein, shown
as host factor X, is suggested to transport the p33/multiprotein-viral RNA complex to the ER as a default mechanism (Jonczyk et al., 2007). Note that TBSV replication is as efﬁcient in
the ER as in the peroxisomes. (C) We propose that the MTS-Pex19p targeted to mitochondria facilitates the re-localization of p33 to the outer membrane of the mitochondria, where
p33 might be less efﬁcient in assembling the functional tombusvirus replicase complex. Step 1 not shown in Panel B and C is the same as in Panel A. See the text for further details.
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ORF sequence (containing the MTS) was ampliﬁed from pGAD-
CIRVp95 by PCR using primers #969 (CCGCGAAGCTTAAAGAT-
GGAGGGTTTGAAGGCTGAGTCT) and #2609 (CCAGGGATCCATCC-
TTACCCTTGAGCTC), followed by ligation with PEX19 cDNA generated
by PCR using primers #1915 and #1916 via three-piece ligation into
pYES digested with HindIII and XhoI.
To construct pYES-MTS-CFP and pGAD-MTS-CFP, we PCR-ampli-
ﬁed the MTS of CIRV p36 ORF sequence ampliﬁed from pGAD-
CIRVp95 by PCR using #969 (CCGCGAAGCTTAAAGATGGAGGGTTT-GAAGGCTGAGTCT) and #2609 (CCAGGGATCCATCCTTACCCTT-
GAGCTC), followed by ligation to the CFP ORF, PCR-ampliﬁed from
pYES-CFP using primers #1291 (CGGCGGATCCGTGAGCAAGGGCGAG-
GAGCTGTTCA) and #2044 (CGACCTCGAGTCATCTAGACTTGTA-
CAGCTCGTCCATGC). Three-piece-ligation based cloning into pYES-
NT/C resulted in pYES-MTS-CFP, and cloning into pGAD generated
pGAD-MTS-CFP.
To construct pYES-HIS-MTS-PEX19, we PCR ampliﬁed the MTS-
PEX19 ORF from the expression plasmid pYES-MTS-PEX19 using
primers #642 (GGAGGAATTCATGGAGGGTTTGAAGGC) and #1916,
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EcoRI and XhoI sites.
To generate pYES-HIS-MTS, the 5′ 684 base pairs of CIRV p36 ORF
sequence was ampliﬁed from pGAD-CIRVp95 by PCR using primers
#642 (GGAGGAATTCATGGAGGGTTTGAAGGC) and #2692 (GGACTC-
GAGTTACCGAGCAGGCTCAACCAA) and then cloning into pYES-NT/C
via EcoRI and XhoI sites. To construct pYES-HIS-PEX19-N206, the 5′
portion of PEX19 ORF representing the N-terminal 206 aa was PCR
ampliﬁed using primers #1915 (CCCGGATCCATGCCAAACATACAACAC-
GAAGTAATG) and #2290 (CCCTCGAGTTATGTTATTGCGTCGTCCATCTC)
and cloned into pYES/NT-C digested with BamHI and XhoI.
The source of antibodies for western blotting
We used the following antibodies in standard Western blotting as
described (Jaag et al., 2007): Anti-His (dilution of 1:20000) from GE
Healthcare, Piscataway, NJ, USA; Anti-FLAG (dilution of 1:10000)
from Sigma-Aldrich, St Louis, MO, USA; Anti-GST (dilution of 1:2000)
from Santa Cruz Biotechnology, Inc Santa Cruz, CA. USA. Anti-pex19
(dilution of 1:20000) from Dr. R. Erdmann, Bochum, Germany; Anti-
Mouse conjugated Alkaline Phosphatase (dilution of 1:20000) from
Sigma-Aldrich St Louis, MO, USA; Anti-Rabbit Alkaline Phosphatase
(dilution of 1:5000) from Sigma-Aldrich, St Louis, MO, USA; and Anti-
Mouse Horse Radish Peroxidase (dilution of 1:15000) from Bio-Rad,
Hercules, CA, USA.
In vitro pull-down assay with recombinant p33
The recombinant TBSV p33, and its derivatives p33ΔN11, p33ΔPTS
and p33C (the C-terminal half of p33, Fig.1A) were expressed as fusion
proteins with maltose binding protein (MBP) in E. coli Epicurian BL21-
CodonPlus (DE3)-RIL (Stratagene, La Jolla, CA, USA) and puriﬁed as
described earlier (Rajendran and Nagy, 2003, 2004). The puriﬁed
recombinantMBP-p33, its derivatives andMBPwere bound to amylose
beads as described (Rajendran and Nagy, 2003).
Yeast strains expressing GST/6xHis-tagged Pex19p or only GST/
6xHis as a control were from the yeast GST-ORF library, in which the
expression is driven by GAL1 promoter (Sopko et al., 2006). Yeast
cells were ﬁrst pre-grown in SC-U− with 2% glucose at 29 °C and then
in SC-U− media with 2% galactose at 29 °C until mid-logarithmic
phase (an optical density at 600 nm=0.8–1.0). Cells were suspended
in binding buffer (20 mM Tris pH 7.5, 100 mM NaCl, 1 mM EDTA, 10%
Glycerol, 0.1% NP-40, 10 mM β-mercaptoethanol and 1% yeast
protease inhibitor mix) and were broken using Talboys™ high
throughput homogenizer (Thorofare, NJ, USA). The total yeast lysate
was cleared by centrifugation at 21,000 ×g for 10 min at 4 °C and then
it was loaded on either MBP-p33 or MBP-immobilized amylose
beads. The binding reaction was performed at 4 °C for 1 h with gentle
rotation. This was followed by washing the beads twice with 1
column volume of binding buffer containing 100 mM NaCl, followed
by two washings of 150 mM NaCl binding buffer and ﬁnally with two
more washings of binding buffer containing 200 mM NaCl. Proteins
retained on the beads were eluted by incubation in SDS-PAGE loading
buffer at 85 °C for 10 min and centrifugation. Samples were subjected
to SDS-PAGE followed by Western blotting with anti-His antibody as
described (Panaviene et al., 2005).
GST-based pull-down of cross-linked Pex19p complex
Yeast BY4741 and pex3Δ strains were co-transformed with pEG
(KT/KG)-GST6xHis-pex19 and pESC-HisFLAGp33 or with pESC-His-
FLAGp33 and pEG(KT/KG)-GST6xHis as a control. For additional
analysis, BY4741 strain was also co-transformed with pEG(KT/KG)-
GST6xHis-pex19 and pESC-HisFLAGp33ΔN11 or pESC-His-
FLAGp33ΔPTS. Transformed yeast cells were cultured in 15-ml
culture tubes containing 3 ml SC-UH− (2% glucose) media for 24 hat 29 °C. Yeast cells were pelleted, and washed with SC-UH− (2%
galatose) media, followed by inoculation to 200 ml SC-UH− (2%
galatose) and culturing at 29 °C until reaching A600 0.8–1.0. Yeast
was pelleted, and washed once with 1X Phosphate Buffer Saline
(PBS) buffer, then suspended in 200 ml 1× PBS buffer, and cooled on
ice. The yeast cells then were treated with 5.5 ml of 37%
formaldehyde (1% ﬁnal concentration) and incubated for 1 h on
ice. The cross-linking reaction was stopped by quenching in 10 ml
2.5 M glycine (ﬁnal concentration 0.125 M). Yeast was then pelleted,
washed once with 1× PBS buffer, and stored at −80 °C. This was
followed by breaking yeast cells in the lysis buffer (1× PBS, 10%
Glycerol, 1 mM EDTA, 0.1% NP-40, 1% yeast protease inhibitor
cocktail™ [Sigma-Ahldrich] and 10 mM β-mercaptoethanol) using a
homogenizer as described above. The unbroken cells were removed
by centrifugation at 100 g for 5 min. The total yeast lysate was
solubilized in the lysis buffer also containing 0.5 M NaCl and 1% NP-
40 via rotation at 4 °C for 1 h, followed by further incubation at 37°C
for 5 min and snap chilling on ice. The solubilized membrane
fraction was centrifuged at 21,000 ×g for 10 min at 4°C. The
supernatant was loaded onto GST-resin (Bio-Rad™ Spin chromato-
graphy column) equilibrated twice with the lysis buffer with 0.5 M
NaCl and 1% NP-40. The samples were rotated for 1 h at 4°C. The
afﬁnity column was drained by gravity ﬂow, washed twice with
600 μl lysis buffer containing 0.5 M NaCl and 1% NP-40, and then
twice with 600 μl lysis buffer, followed by centrifugation at 1000 ×g
for 2 min. The bound proteins were then recovered from the column
in 50 mM Tris buffer containing 20 mM glutathione in a two-step
elution. Finally, the protein samples were incubated at 100°C for
20 min to reverse cross-linking, and mixed with the SDS sample
buffer and subjected to SDS-PAGE and western blotting using anti-
FLAG antibody. The detection of FLAG was via chemiluminescence
according to manufacturer’s recommendations (GE Healthcare,
Piscataway, NJ, USA).
A two-step His/FLAG afﬁnity-based co-puriﬁcation of the viral replicase
and Pex19p
This procedure is the modiﬁcation of a previously published
approach (Serva and Nagy, 2006). Brieﬂy, yeast SC1 strain were
transformed to express 6xHis/FLAG-tagged p33 or only 6xHis-tagged
p33 together with plasmids expressing p92 and DI-72 repRNA. The
yeast were grown at 23 °C until reaching OD600 0.8–1.0. 200 mg of
yeast was resuspended and homogenized in TG buffer (50 mM Tris–
HCl [pH 7.5], 10% glycerol, 15 mM MgCl2, and 10 mM KCl) buffer
supplemented with 0.5 M NaCl, 0.1% Nonidet P-40 (NP-40), and 1%
yeast protease inhibitor cocktail by glass beads using Talboys™ high
throughput homogenizer (Thorofare, NJ, USA). The cell debris was
removed by centrifugation for 5 min at 100 ×g at 4 °C. The enriched
membrane fraction containing the active viral replicase complex was
collected by centrifugation for 15 min at 21,000 ×g at 4 °C and then
solubilized in 1 ml TG buffer with 0.5 M NaCl, 1% NP-40, 5% SB3–10
[caprylyl sulfobetaine] [Sigma] via gentle rotation for 2 h at 4 °C. The
samples were then incubated at 37 °C for 5 min and centrifuged at
21,000 ×g at 4 °C g for 15 min. 5 mM imidazole was added to the
supernatant, followed by gently rotation for 1 h at 4 °C with
ProBond resin (Invitrogen) pre-equilibrated with TG buffer supple-
mented with 0.5 M NaCl and 1% NP-40 and 5% SB3–10. The unbound
materials were removed by gravity ﬂow, and the resin was washed
twice with TG buffer supplemented with 0.5 M NaCl, 1% NP-40, and
1% SB3-10. The resin-bound proteins were eluted in 200 μl TG buffer
supplemented with 0.5 M NaCl, 1% NP-40, 1% SB3-10 and 300 mM
imidazole. The eluates were then loaded onto anti-FLAG M2-agarose
afﬁnity gel (Sigma) pre-equilibrated with 0.6 ml TG buffer
supplemented with 0.5 M NaCl, 1% NP-40, 1% SB3-10 and 1% yeast
protease inhibitor cocktail. After 2 h gentle rotation at 4 °C, the
unbound materials were removed by gravity ﬂow and the resin-
304 K.B. Pathak et al. / Virology 379 (2008) 294–305column was washed 3 times with 1 ml TG buffer with 0.5 M NaCl,
1% NP-40, and 1% SB3-10 and twice with 1 ml TG buffer with
150 mM NaCl and 0.1% NP-40. Proteins bound to afﬁnity bead were
eluted by incubating in SDS-PAGE loading buffer at 85 °C for 10 min
and the subjected to SDS-PAGE and western blotting with anti-
Pex19 antibodies (generous gift from Dr. R. Erdmann).
Confocal laser microscopy
Yeast strains BY4741 and pex19Δ were co-transformed with
pESC-DI72-YFPp33 under GAL1 promoter, pGAD-MTS-CFP (as mito-
chondrial protein marker) under ADH1 promoter and pYES-MTS-
PEX19 or pYES-HISPEX19 behind GAL1 promoter. In another set of
experiments, above strains were transformed with GAL1 controlled
pYES-MTS-CFP and pESC-DI72-YFPp33. Yeast transformants were
pre-grown in SC-ULH- media supplemented with 2% glucose for
16 h at 29 °C and then transferred to 2% galactose media, followed
by shaking at 29 °C. Samples were collected at 7 h and 24 h for
confocal microscopy.
Confocal laser scanning micrographs were acquired on an
Olympus FV1000 microscope (Olympus America Inc., Melville,
New York) as described earlier (Jonczyk et al., 2007). ECFP was
excited using 440 nm laser light, attenuated to 4.5–11.0% of the
maximum laser power, while EYFP was excited using 515 nm laser
line (3.5–8.0% of the maximum laser power). The images were
acquired using sequential line-by-line mode in order to reduce
excitation and emission cross-talk. The primary objective used was
a water-immersion PLAPO60XWLSM (Olympus). Image acquisition
was conducted at a resolution of 512×512 pixels and a scan-rate of
10 μs/pixel. Image acquisition and exportation of TIFF ﬁles were
controlled by using Olympus Fluoview software version 1.5. Figures
of micrographs were assembled using Photoshop 9.0 (Adobe
Systems Incorporated, San Jose, CA).
Replication assay
The p92 replication protein with N-terminal 6xHis-tag was
expressed constitutively in S. cerevisiae strains from pGAD-His92
plasmid under ADH1 promoter, while the 6xHis-tagged p33 and the
full-length DI-72(+)RNA were launched from a dual-expression
construct, pESC-DI72-p33 based on the galactose-inducible GAL1
and GAL10 promoters, respectively. Pex19p and its mutant derivatives
were expressed under GAL1 promoter. Yeast strains (BY4741 and
pex19Δ) were pre-grown in SC-ULH− medium containing 2% glucose.
After 16 h shaking at 29 °C, the cultures were transferred to 2%
galactose media and grown for additional 24 h at 29 °C. Total RNA
extraction and Northern-blotting was performed as described
(Serviene et al., 2006) using probe RIII/IV(−), which selectively binds
to the 3′ end region of the plus-stranded TBSV DI-72 RNA. The
quantitative analysis was performed using phospho-imaging with a
Typhoon (GE) instrument as described (Panaviene et al., 2004;
Serviene et al., 2006).
In vitro replicase assay
The isolation of the membrane-enriched fraction from yeast cells
was similar to that developed earlier (Panaviene et al., 2005, 2004).
The template activities of the obtained replicase preparations were
tested after adjusting for the same amount of p33 proteins in the
samples (Panaviene et al., 2005).
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